← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Genvec, Inc.
Gaithersburg, MD
$11,771,489
Total funding
24
Grants
Funding over time
peak $2.8M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$11,986,574 · 25
By mechanism
R43$7,255,002 · 19
R44$3,831,482 · 3
R21$546,430 · 1
R41$353,660 · 2
Investigators at Genvec, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Production of Adenovector Based Vaccines$899,329
R44 · FY2011 · AI
Production of Adenovector Based Vaccines$886,735
R44 · FY2010 · AI
Production of Adenovector Based Vaccines$684,896
R44 · FY2009 · AI
Novel Adenovirus Vectors for Biodefense Vaccines$433,476
R43 · FY2006 · AI
Development of PEDF Protein: An Antiangiogenic Agent$413,395
R44 · FY2004 · EY
Evaluation of High-Capacity Adenovectors in the Eye$369,329
R44 · FY2006 · EY
Development of PEDF Protein: An Antiangiogenic Agent$362,389
R44 · FY2005 · EY
Alternate Adenovector in Eye Gives Longer Expression$329,500
R43 · FY2007 · EY
Novel regulation of the anti-angiogenic activity of PEDF by pro-angiogenic MMPs$311,364
R21 · FY2008 · EY
Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development$300,000
R43 · FY2012 · AI
Adenovirus-vectored RSV vaccine not inhibited by maternal immunity$300,000
R43 · FY2012 · AI
Preclinical Testing of an Adenoviral Vector based HSV-2 Vaccine$300,000
R43 · FY2008 · AI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination$300,000
R43 · FY2008 · AI
Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development$300,000
R43 · FY2013 · AI
Preclinical Testing of an Adenoviral Vector based HSV-2 Vaccine$300,000
R43 · FY2009 · AI
High Throughput Genomics Screening for Malaria Antigen Discovery$300,000
R43 · FY2009 · AI
Adenovirus Vectors for Respiratory Syncytial Virus Vaccination$300,000
R43 · FY2009 · AI
High Throughput Genomics Screening for Malaria Antigen Discovery$300,000
R43 · FY2010 · AI
Novel Ad5 Malaria Vaccine That Circumvents Pre-existing Ad5 Immunity$299,889
R43 · FY2008 · AI
Production of Adenovector Based Vaccines$299,758
R43 · FY2005 · AI